Corporate Profile
Selected Papers
XB Modeler
Cardiotoxicity Hazard Map/ECG Data Base COMING SOON
Contact Us


The world’s leading technologies open the new door for:
  • Patient-specific heart simulation for optimal therapy
  • In silico evaluation of cardiotoxicity and drug discovery
  • In silico bench test for novel medical devices
  • Research to bridge molecular biology and clinical medicine

(C) 2018 UT-Heart Inc.